---
title: Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
date: '2024-06-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38842520/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20240606180821&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: The combination of 10-mg bulevirtide plus peginterferon
  alfa-2a was superior to bulevirtide monotherapy with regard to an undetectable HDV
  RNA level at 24 weeks after the end of treatment. (Funded by Gilead Sciences; MYR
  204 ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: The combination of 10-mg bulevirtide plus peginterferon alfa-2a was superior to bulevirtide monotherapy with regard to an undetectable HDV RNA level at 24 weeks after the end of treatment. (Funded by Gilead Sciences; MYR 204 ClinicalTrials.gov number, ...